Professor John Mills, Executive Chairman, Cavidi AB, SB MD FACP FRACP ARCPA, Association of American Scientists (AAAS), Fellow Infectious Disease Society of America, Member Australasian Society of HIV Medicine, Community service Chair, Research Committee, and Director, Prostate Cancer Foundation of Australia, also Managing Director, TissuPath Pty Ltd, Non-executive Director of GBS Venture Partners P/L and Non-executive Director of Phosphagenics Corp (ASX: POH).
Professor Suzanne Crowe, AM, Macfarlane Burnet Institute for Medical Research and Public Health: Head, Pathogenesis and Clinical Research Program Centre for Virology, Head of Flow Cytometry Laboratory, Head of Clinical Research Laboratory. Consultant Physician in Infectious Diseases and General Medicine, Alfred Hospital, Melbourne, Professor of Medicine and Infectious Diseases (Personal Chair), Monash University, Melbourne, NHMRC Principal Research Fellow, awarded Member of the Order of Australia (AM) for her service to medical research in HIV/AIDS medicine and infectious diseases.
Dr. Brendan Larder, Chair RDI Scientific Core Group. Dr Larder is one of the world's leading experts in the fields of HIV drug resistance and pharmacogenomics. He holds a PhD in Virology from Cambridge University. Dr. Larder discovered HIV drug resistance. His seminal work on AZT resistance and its genetic basis published in Science in 1989. Dr. Larder has continued to pioneer understanding in the field, unraveling the genetic basis of resistance to several other HIV drugs and developing many of the laboratory techniques for studying HIV drug resistance, including phenotyping and genotyping methodologies.
Professor Anders Sönnerborg, adjunct professor in infectious disease Virology at the Department of Medicine, Karolinska University Hospital, Sweden. Anders focuses on research concerning mechanisms of resistance and failure to improve HIV-specific immunity in HIV treatment. In vitro experiments in model systems combined with experimental analysis of well-defined patient populations.
Associate Professor Johan Lennerstrand, Associate professor Section of Virology, Department of Medical Sciences, Uppsala University and University Hospital, Uppsala, Sweden.
Ex-officio members: Clas Källander, Founder and Director of R&D, CAVIDI AB, Ingvar Petersson, Scientific Affairs Manager, CAVIDI AB.